Shao F, Xu S, Ma X, Xu Z, Lyu J, Ng M. (2020) In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation. doi:10.1016/j.resuscitation.2020.04.005

https://www.sciencedirect.com/science/article/pii/S0300957220301428

In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China

University of Michigan - Ann Arbor

- Resuscitation
- Convalescent Plasma (CP) Transfusion

COVID-19 Patient Interventions

This study is the first to report the clinical characteristics and outcomes of patients with severe COVID-19 illness and in-hospital cardiac arrest. Performing CPR on COVID-19 patients poses significant risk to healthcare workers due to intubation and chest compressions creating opportunities for transmission to occur at a higher level. Evaluating the success of CPR in patients with cardiac arrest is extremely relevant. 

Resuscitation and Associated Outcomes in COVID-19 Patients in Wuhan, China

- Proceedings of the National Academy of Sciences of the United States of America (PNAS)
- The Journal of Clinical Investigation (JCI)
- American Society of Hematology
- The Journal of the American Medical Association (JAMA)
- Food and Drug Administration (FDA)

References for COVID-19 Papers on CP Transfusion by Journal/Source

Convalescent plasma (filtered plasma containing antibodies from recovered individuals) is a treatment option with ongoing research. It can be used as treatment for severely ill patients or as prophylaxis for highly susceptible individuals. While many patients show marked improvement in symptoms, studies involving CP also include other treatment, so the sole effectiveness of CP transfusion is yet unclear. Recovered individuals are encouraged to donate their plasma for research and recovery.

Learn Before

Related

Learn After